Clinique Générale-Beaulieu

Dr. med. Mathieu Chevallier

Medical oncology
General Internal Medicine

Languages

FR EN

Areas of specialisation (2)

Download vCard

Download CV

Contact me

Hospital (1)

Générale-Beaulieu Swiss Oncology Network
Chemin de Beau-Soleil 20
1206 Genève

cabinet.chevallier@beaulieu.ch

022 839 57 98

Education

After completing his studies at the University of Geneva, Dr Chevallier specialised in general internal medicine and then in medical oncology. He is passionate about the management of oncological diseases and personalised treatments, with a rigorous scientific medical approach and the support of complementary therapies.

2022: FMH specialist title in oncology

2018: FMH specialist title in general medicine

2007 - 2011: University of Geneva, Federal Diploma in Medicine

2005: EPFL, Life Sciences and Technologies

Memberships

Swiss Society for Medical Oncology (SSOM)
European Society for Medical Oncology (ESMO)
Swiss Medical Association (FMH)
Association of Doctors of the Canton of Geneva (AMGe)

Work Experience

Clinical head of the oncology department at the HUG

Medical oncology, clinical research unit, inpatient and outpatient care
Pre- and post-graduate medical teaching at the University of Geneva and Haute Ecole de Santé

Internal and general medicine (inpatient, outpatient, emergency, geriatrics)

Publications

Rare Synchronous Lung Cancers in a Nonsmoker with Epidermal Growth Factor Receptor and Mesenchymal-Epithelial Transition Alterations: A Case Report.
Baer X, Chevallier M, Rey Cobo J, Plojoux J, De Vito C, Addeo A. Case Rep Oncol. 2024 Apr 12;17(1):549-555. doi: 10.1159/000538019. eCollection 2024 Jan-Dec. PMID: 38618277

Pleural Mesothelioma in the Era of Immunotherapy
Chevallier M, Kim F, Friedlaender A, Addeo A. Clin Med Insights Oncol. 2023 Jul 20;17:117955. doi: 10.1177/11795549231178173. eCollection 2023. PMID: 37492425

Immunodeficiency and Lymphoma in Jacobsen Syndrome.
Nigolian H, Nieke JP, Chevallier M, Stathaki E, Sloan-Béna F, Carminho-Rodrigues MT, Jandus P. J Investig Allergol Clin Immunol. 2022 Oct 11;32(5):408-409. doi: 10.18176/jiaci.0777. Epub 2022 Jan 14.PMID: 35029149

Oncogenic driver mutations in non-small cell lung cancer: Past, present and future.
Chevallier M, Borgeaud M, Addeo A, Friedlaender A. World J Clin Oncol. 2021 Apr 24;12(4):217-237. doi: 10.5306/wjco.v12.i4.217.PMID: 33959476

The Impact of Variant Allele Frequency in EGFR Mutated NSCLC Patients on Targeted Therapy.
Friedlaender A, Tsantoulis P, Chevallier M, De Vito C, Addeo A. Front Oncol. 2021 Mar 30;11:644472. doi: 10.3389/fonc.2021.644472. eCollection 2021.PMID: 33869038

Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer.
Chevallier M, Tsantoulis P, Addeo A, Friedlaender A. Cancer Genomics Proteomics. 2020 Sep-Oct;17(5):597-603. doi: 10.21873/cgp.20216.PMID: 32859638

Vertebral Metastasis Treated by Vertebroplasty, a Cause of Respiratory Failure: Case Report and Literature Review.
Chevallier M, Chevallier-Lugon C, Friedlaender A, Addeo A. Case Rep Oncol. 2021 Mar 2;14(1):279-283. doi: 10.1159/000513492. eCollection 2021 Jan-Apr.PMID: 33776717

[The general practitioner: an essential actor to ensure a specific management in oncologic patients].
Chevallier M, Chevallier-Lugon C, Pernin T. Rev Med Suisse. 2019 Jun 5;15(654):1188-1192.PMID: 31166671 French.

Doctors with this specialisation

Clinique Générale-Beaulieu

Centres

Maternity

Patients & visitors

About us

Centres

Maternity

Patients & visitors

About us

Générale-Beaulieu Search

Dr. med. Mathieu Chevallier

Contact me

Education

Memberships

Work Experience

Publications

Doctors with this specialisation

Dr. med. Vincent Dombre

Dr. med. Laurent Pinget

Dr. med. Samir Vora

Dr. med. Marc D'Espine

Dr. med. Maria-Aikaterini Papadopoulou

Dr. med. Diego Araoz